Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

计划入组 400 人 · 首次发布于 2025 年 12 月 23 日

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

计划入组 260 人 · 首次发布于 2026 年 5 月 14 日

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

计划入组 60 人 · 首次发布于 2024 年 11 月 25 日

C213 Microneedle System

drug delivery system

endocannabinoid system activator

Affera, Inc.

United States

Ryder System

United States

GOSHEN HEALTH SYSTEM

United States

Medtronic's Affera System Receives FDA Approval for Atrial Fibrillation Treatment

Medtronic's Affera System Receives FDA Approval for Persistent Atrial Fibrillation Treatment

FDA Approves Medtronic's Affera System for Atrial Fibrillation Ablation